Composition for anti-inflammation, wound healing or wound healing promotion, comprising rose stem cell-derived exosomes as active ingredient
AssigneeExoCoBio Inc.
InventorByong Seung Cho
Life of this patent
Estimating the term…
Abstract
A composition containing rose stem cell-derived exosomes as an active ingredient is provided for anti-inflammation, wound healing or wound healing acceleration. The composition has excellent effects on anti-inflammation, wound healing and/or wound healing acceleration.
Claims9
A method for reducing a level of interleukin-6 (IL-6) thereby suppressing, alleviating, ameliorating or treating dermatitis, atopic dermatitis, eczema, inflammation caused by infections, and inflammation caused by wounds in a subject in need thereof, the method comprising administering an anti-inflammatory composition to an area of skin of the subject, wherein said area of the skin is affected by dermatitis, atopic dermatitis, eczema, inflammation caused by infections, or inflammation caused by wounds, wherein the anti-inflammatory composition comprises exosomes derived from rose stem cells as an active ingredient, and wherein the exosomes are isolated from a conditioned medium of the rose stem cells.
A method for reducing a level of IL-6 thereby suppressing, alleviating, ameliorating or treating dermatitis, atopic dermatitis, eczema, inflammation caused by infections, and inflammation caused by wounds in a subject in need thereof, the method comprising topically applying an anti-inflammatory composition to an area of skin of the subject, wherein said area of the skin is affected by dermatitis, atopic dermatitis, eczema, inflammation caused by infections, or inflammation caused by wounds, wherein the anti-inflammatory composition comprises exosomes derived from rose stem cells as an active ingredient, and wherein the exosomes are isolated from a conditioned medium of the rose stem cells.
Dependencies are inferred from the claim text.